Vident Investment Advisory, LLC Nkarta, Inc. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$12.27 - $18.39 $68,945 - $103,333
-5,619 Reduced 9.68%
52,435 $690,000
Q2 2022

Aug 15, 2022
BUY
$7.77 - $19.44 $451,079 - $1.13 Million
58,054 New
58,054 $715,000
Q2 2021

Aug 13, 2021
SELL
$23.94 - $36.68 $545,832 - $836,304
-22,800 Closed
0 $0
Q4 2020

Feb 08, 2021
BUY
$27.03 - $75.62 $616,284 - $1.72 Million
22,800 New
22,800 $1.4 Million

Others Institutions Holding NKTX

# of Institutions
129
Shares Held
66.5M
Call Options Held
173K
Put Options Held
20K
View Full List

About Nkarta, Inc.

NKTX Quotes by TradingView
  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $119M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email